CHEMICAL/BIOLOGICAL DEFENSE (ATD)

Abstract

Demonstrates technologies supporting transition to advanced component development in the areas of physical capabilities (biological and chemical detection, situational awareness and effects modeling, and protection and hazard mitigation) and medical capabilities (pretreatments, therapeutics, diagnostics capabilities, and drug manufacturing and regulatory science technologies), including capabilities against non-traditional agents. Major efforts support enhanced chemical detection capabilities for aerosols and non-traditional agents, expanded capabilities for biosurveillance in pathogen detection and diagnosis, and pretreatments and therapeutics against a broader set of chemical and biological agents. In the physical sciences area, Project CB3 focuses on demonstrations of CB defense technologies, including biological detection, chemical detection, information system technology for hazard prediction and systems performance, and protection, and decontamination. The Project continues to pursue solutions against traditional agents. All non-traditional agent (NTA)-dedicated research (both medical and non-medical) is consolidated in Project NT3. This Project includes NTA chemical diagnostics, medical pretreatments, therapeutics, detection, and protection and hazard mitigation. The medical program in Project TM3, aims to produce biological diagnostic assays and reagents, diagnostic device platforms, pretreatments and therapeutics for bacterial, viral, and toxin threats as well as for chemical threats, and medical devices, as countermeasures for CBR threat agents. Specific areas of medical investigation include: prophylaxis, pretreatment, antidotes and therapeutics, personnel and patient decontamination, and medical management of casualties. Project TT3, Techbase Technology Transition, pursues efforts to enhance military operational capability, concepts of operation, WMD elimination, and hazard mitigation following a biological warfare or chemical warfare attack. The PE is dedicated to conducting proof-of-principle field demonstrations, and testing system-specific technologies to meet specific military needs. Work conducted under this PE will transition to and will provide risk reduction for PE 0603884BP/PE 0604384BP activities. FY 2015 funding includes $132.7 million of base funding and $22.7 million of Ebola emergency funding.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2016
Source ID
0603384BP_3_0400_PB_2016
Change Summary Explanation
Funding: N/A Schedule: N/A Technical: N/A
Service Agency Name
Chemical and Biological Defense Program

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Acquisition
  • Biological Factors
  • Chemical Detection
  • Chemical Warfare
  • Chemical Warfare Agents
  • Detection
  • Detectors
  • Information Systems
  • Materials
  • Medical Countermeasures
  • Medical Personnel
  • Nerve Agents
  • Test And Evaluation
  • Therapy
  • United States European Command
  • United States Transportation Command
  • Warfare

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.
  • Military Science and Technology Research and Modernization.

Technology Areas

  • Biotechnology

Related Documents